CDXS today
$0.96-$0.02 (-1.98%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minLeaning Bullish
5 minSymmetric Triangle
Daily trend turns up above $1.22
Key levels
Resistance$1.22
Resistance$1.04
Latest news & SEC filings
DealCodexis secures $60M financing through a new credit deal
SEC FilingCodexis, Inc. filed a report on a major company event (Form 8-K)
All CDXS news →About Codexis
Codexis provides enzyme engineering technology to improve manufacturing of therapeutics. It uses its CodeEvolver platform to develop enzymes for RNAi therapeutics production and for small molecule drug manufacturing. Customers include large pharmaceutical companies and contract development and manufacturing organizations. The company operates in the United States.
Based on the company's 10-K filed Mar 11, 2026.
Nasdaq · Basic Materials
CODEXIS, INC. (CDXS)
What Is the Price Target for CDXS?
SEPT Low Target
$8.00
SEPT Mid Target
$8.00
SEPT High Target
$8.00
Analyst Consensus
$8.00
Is CDXS a Buy or Sell Right Now?
Thesis
- •Revenue growing 18.6% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CDXS.
Start Free Trial →Is CDXS Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$6.21
17
Moat Score
NONE
3/9
Piotroski Score
-5.0
Altman Z-Score
What Is Smart Money Doing with CDXS?
Insider Signal
SELLING
0 buys / 8 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| De Vre Raymond | director | Sale | 1,088 | $1K | Nov 9, 2026 |
| Erbez Georgia | officer | Sale | 6,335 | $9K | Oct 12, 2026 |
| MOORE ALISON | director officer | Sale | 6,335 | $9K | Oct 12, 2026 |
| De Vre Raymond | director | Sale | 2,605 | $6K | Jun 11, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CDXS Growth Story
Revenue YoY
18.6%
3yr Revenue CAGR
-20.2%
EPS Growth YoY
43.82%
FCF Growth YoY
55.6%
Revenue Trend
ACCELERATING
Dark Pool Trades for CDXS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CDXS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:38:02 | $0.95 | 1,000 | $$955 | BUY |
| 14:32:31 | $0.95 | 2,000 | $$2K | SELL |
| 13:46:41 | $0.97 | 1,000 | $$973 | SELL |
| 13:42:04 | $0.97 | 1,000 | $$974 | SELL |
| 21:26:02 | $0.98 | 21,398 | $$21K | SELL |
5 dark pool trades shown · $$26K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CODEXIS, INC. (CDXS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CDXS — frequently asked questions
What is CDXS stock price today?
CODEXIS, INC. (CDXS) is at $0.96, down 1.98% (-$0.02) at the Nov 12, 2026 close.
Why is CDXS stock moving today?
Latest CDXS news — Nov 10, 2026: Codexis secures $60M financing through a new credit deal · Nov 10, 2026: Codexis, Inc. filed a report on a major company event (Form 8-K)
Why did CDXS stock move on Nov 10, 2026?
Codexis shares fell 10.71% to close at $1.00 after the company announced a $60 million asset-backed term loan and filed a Form 8-K disclosing a major company event. The financing arrangement, which carries dilution risk, weighed on investor sentiment throughout the session as the stock traded down to its low of $1.00 on volume of 630,089 shares.
What is the CDXS price target?
The average analyst price target for CDXS is $8.00, ranging from $8 to $8, based on 1 analysts. Latest: Piper Sandler maintains on Aug 17, 2026.
What do analysts rate CDXS?
Analyst ratings for CDXS: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did CDXS beat earnings?
CDXS last reported on Aug 11, 2026: EPS -$0.13 vs -$0.14 expected — a beat of 8.3%.
Does CDXS pay a dividend?
CDXS does not currently pay a dividend.
How much debt does CDXS have?
CODEXIS, INC. reported $41M of debt and $27M of cash (Jun 30, 2026).
What are CDXS support and resistance levels?
Resistance: $1.04, $1.22, $1.35.
What are insiders doing with CDXS?
Insider activity: SELLING, 0 buys and 8 sells in the last 90 days.
What is the latest news on CDXS?
Nov 10, 2026: Codexis secures $60M financing through a new credit deal · Nov 10, 2026: Codexis, Inc. filed a report on a major company event (Form 8-K)